What Researchers Did
Researchers investigated the effects of hyperbaric oxygen therapy (HBOT) and dimethyl sulfoxide (DMSO) on tissue necrosis, genotoxicity, and cell apoptosis in random skin flaps created in 50 male Wistar rats.
What They Found
While the percentage of necrosis was not significantly different between groups, the cell viability index varied significantly (P < 0.001), with the HBOT group showing the highest viability at 91% compared to 87.40% in controls. The HBOT group also exhibited the lowest genotoxicity (7.20% cells with DNA damage) and a reduced cell apoptosis index (9.00) compared to controls (22.80% and 12.60, respectively).
What This Means for Canadian Patients
This preclinical study suggests that hyperbaric oxygen therapy might potentially improve cell viability and reduce DNA damage and apoptosis in compromised tissues. If these findings translate to humans, HBOT could be a beneficial adjunct therapy for patients undergoing reconstructive surgery involving skin flaps, potentially improving tissue survival.
Canadian Relevance
This study was not conducted in Canada and does not have a direct Canadian connection.
Study Limitations
A significant limitation of this study is its use of a rat model, meaning the findings may not directly translate to human physiology or clinical outcomes.